ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

AOR And PRN, Two Largest Oncology Practice Management Firms, To Merge

December 18, 1998

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

AACR Selects Eight Finalists To Compete For $15 Million Grants Funded By Telethon.

December 5, 2008

Zerhouni to Cancer Researchers: “Stay Calm, Cool” About Funding- And Beware of Myths.

June 16, 2006

NCI Cancer Prevention Fellowship Program

April 28, 2000

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990